Navigation Links
Countdown to MD&M West 2013: Eleven Days until the Most Comprehensive MedTech Conference in the Nation
Date:1/31/2013

ANAHEIM, California, January 31, 2013 /PRNewswire/ --

More than 500 high-level MedTech professionals in all functions, and from all over the world, will convene at the 2013 MD&M West Conference.  MD&M West is one of the most anticipated face-to-face gatherings for those involved in medical device design and manufacturing. The four-day Conference takes place Feb. 11-14, 2013 at the Anaheim Convention Center. To reserve your space, visit http://www.MDMWestConference.com.

     (Logo: http://photos.prnewswire.com/prnh/20130131/593901)

The 2013 Conference will host six FDA/CDRH (Center for Devices and Radiological Health) officials, who will be speaking on timely medical device industry topics:

Randall Brockman
Acting Chief Medical Officer, Office of Device Evaluation, FDA/CDRH

Topic: FDASIA Recap: Clarifying the review process and the benefit-risk determinations for PMA and de novo applications

Don St. Pierre

Deputy Director for New Product Evaluation, Office of In Vitro Diagnostic Device Evaluation & Safety, FDA/CDRH

Topic: Reviewing the 510(k) Triage and Quick Review pilot program and an update on the new process, including the RTA policy change

Alonza Cruse
District Director, FDA Los Angeles District

Topic: FDA Los Angeles District Update and the FDA Globalization Initiative

Dan Solis
Director of Import Operations, FDA Los Angeles District

Topic: Update on Los Angeles Import Operations Activities

Ron Kaye
Team Leader; Human Factors Pre-Market Evaluation Team, Office of Device Evaluation, FDA/CDRH

Topic: Hu
'/>"/>

SOURCE UBM Canon
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Countdown Begins For AdvaMed 2012: The Medtech Conference
2. Nelson Laboratories to Host Free Educational Device Testing Classes at 2013 MD&M West Show
3. Call for Papers: MD&M West 2013 Conference for Medical Device Design and Manufacturing
4. MD&M Minneapolis Conference Returns to the Twin Cities this October
5. Edwards Lifesciences Chief Medical Officer to Keynote the Inaugural MedTech Cardio 2012 Conference at the MD&M Minneapolis Exposition and Conference
6. Medical Device Developers - Network at MD&M East Next Week
7. The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market
8. The Economists Pharma Summit 2013: Back to Basics - the Real Business of Pharma
9. Arab Health 2013: Package Solution for Mobile Hybrid Rooms
10. Medical Devices 2013: A Frost & Sullivan Executive MindXchange- Sustaining the Vitality of the Industry and Your Company
11. Angus Russell to Retire in 2013: Dr Flemming Ornskov to Succeed as Chief Executive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... VANCOUVER, British Columbia , May 22, 2013  OncoGenex ... the development of novel therapeutics to target mechanisms of treatment ... investigational compounds, custirsen and OGX-427, will be presented as "Trials ... of the American Society of Clinical Oncology (ASCO) in ... 4. Despite the availability of drugs that ...
(Date:5/21/2013)... , May 21, 2013 Reaching a ... process, the National Association of Boards of Pharmacy ® ... the .PHARMACY domain suffix has passed the Internet Corporation ... intends to launch the .PHARMACY gTLD by the end ... to legitimate online pharmacies and related entities that are ...
(Date:5/21/2013)... SAN FRANCISCO , May 21, 2013 /PRNewswire/ ... meeting of the American Psychiatric Association show that ... statistically and clinically meaningful response and remission in ... acute phase of therapy, which were maintained through ... acute treatment, 62 percent of patients achieved symptomatic ...
Breaking Medicine Technology:OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 2NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 4
... TOKYO and CHIPPENHAM, England, October 7 ,Sosei ... and Vectura,Group plc ("Vectura"; LSE: VEC), announce ... efficacy, safety and tolerability of NVA237 presented ... Society (ERS) in Berlin,Germany. The new data ...
... of Gastroenterology Annual ... ... two Phase 3,studies presented at the American College of Gastroenterology Annual,Scientific ... rates than lansoprazole among patients with more,severe grades of erosive esophagitis ...
Cached Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 2Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 3
(Date:5/22/2013)... from the University of Melbourne said this small increase ... benefits from CT scans in diagnosing and monitoring disease. ... British Medical Journal today and involved researchers at ... International Agency for Research on Cancer in Lyon, France. ... useful in providing detailed three dimensional pictures to diagnose ...
(Date:5/22/2013)... King of Prussia, PA (PRWEB) May 22, 2013 ... is proud to announce its participation in the Greater Philadelphia ... experienced cyclists and recreational riders who are passionate about stopping ... affects more than 25 million Americans. , The Tour ... Ambler Campus, located at 580 Meetinghouse Road in Ambler, 30 ...
(Date:5/22/2013)... 22, 2013 CoCENTRIX, a leading ... Health and Human Services and community providers, announced ... (ADMH) selected the CoCENTRIX Coordinated Care Platform ... the Health Records and coordinate care within and ... , CoCENTRIX is transitioning the hospitals' official records ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Hypervibe, a ... machines , announced today that the company’s US division ... Sunday, and Monday. Military personnel ordering the Hypervibe Performance ... when they show a valid military ID. Non-military customers ... that values commitment, honor, and integrity. These are values ...
(Date:5/22/2013)... Chicago, IL (PRWEB) May 22, 2013 ... and are looking for education on how to lose ... thresholds can be challenging and may demotivate people to ... A new study discussed this week on Medical ... that learning how to lose weight and actually losing ...
Breaking Medicine News(10 mins):Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 2Health News:The State of Alabama Selects the CoCENTRIX Coordinated Care Platform to Facilitate Care for Its Citizens Treated in State Psychiatric Hospitals 3Health News:Hypervibe Whole Body Vibration Offers First-Ever Sale This Memorial Day Weekend 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 3
... researcher has co-authored an international study that revealed a drug ... a rare lung disease in women. The life-threatening disease ... The clinical trial of the drug -- called sirolimus -- ... therapy for the lung disease, lymphangioleiomyomatosis, or LAM. LAM ...
... The wrist size of overweight or obese children and teens ... says a new study. Italian researchers measured the wrist ... They also used a painless nuclear imaging technique on about ... areas of the wrist more precisely. Blood tests were ...
... MONDAY, April 11 (HealthDay News) -- A drug commonly prescribed ... treating the mild stage of the disease, a new study ... effective in treating moderate to severe Alzheimer,s disease, "in mild ... works," said lead researcher Dr. Lon S. Schneider, a professor ...
... new discovery published online in The FASEB Journal ( ... likely to benefit from breast cancer drug therapies. If ... it would represent a significant advance for breast cancer ... some people. In addition, some drugs have side effects ...
... How your carotid artery moves can reveal your risk of ... study this vessel aspect in more detail thanks to a ... with suspected coronary artery disease, reveals a thesis from the ... arteries is associated with a risk of future heart disease, ...
... the journal Investigational New Drugs and conducted by researchers ... molecule inhibitors are showing promise in blocking STAT3, a ... osteosarcoma. These small molecule inhibitors one derived from ... as a new, non-toxic treatment for these deadly tumors. ...
Cached Medicine News:Health News:OHSU expert co-authors study finding treatment for rare lung disease 2Health News:Drug Memantine Ineffective for Mild Alzheimer's, Study Finds 2Health News:Drug Memantine Ineffective for Mild Alzheimer's, Study Finds 3Health News:Tiny antibody fragments raised in camels find drug targets in human breast cancer cells 2Health News:New potential atherosclerosis risk marker discovered 2Health News:New study finds compounds show promise in blocking STAT3 signaling as treatment for osteosarcoma 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: